Angiotensin-Converting Enzyme 2 Activator Ameliorates Severe Pulmonary Hypertension in a Rat Model of Left Pneumonectomy Combined With VEGF Inhibition

Background: Pulmonary arterial hypertension (PAH) is a life-threatening and deteriorating disease with no promising therapy available currently due to its diversity and complexity. An imbalance between vasoconstriction and vasodilation has been proposed as the mechanism of PAH. Angiotensin-convertin...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, I-Chen, Lin, Jao-Yu, Liu, Yi-Ching, Chai, Chee-Yin, Yeh, Jwu-Lai, Hsu, Jong-Hau, Wu, Bin-Nan, Dai, Zen-Kong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933511/
https://www.ncbi.nlm.nih.gov/pubmed/33681251
http://dx.doi.org/10.3389/fmed.2021.619133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933511/
https://www.ncbi.nlm.nih.gov/pubmed/33681251
http://dx.doi.org/10.3389/fmed.2021.619133

Ejemplares similares